Skip to content

TXG

10x Genomics, Inc.

Stock

$93.50+4.74 (+5.34%)Close Oct 2, 2026

Operating income, 2025
−$61M

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025−$61M—
2024−$195M—
2023−$265M—
2022−$168M—
2021−$52M—
2020−$534M—
2019−$31M—
2018−$111M—
2017−$18M—